Our in-clinic system detects an epigenic bio marker in free urinary linked to malignancy, using molecularly imprinted polymer capture and spectrophotometric readout. A single urine sample from a dog or cat delivers a clear Positive/Negative result on the device during the visit no blood draw, no sedation, no send-out lab. In an independent clinical validation under university ethics committee oversight, UriBx achieved 98% sensitivity and 100% specificity. Designed as a first-line screen to guide further work-up. Visit us at stand 606 Hall B across the Stempelrun next to Belgisch Kankerfonds.